Q4 2024 Holdings
Filed 2025-02-14 | 61 holdings | $457.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $31.3M | 400,014 | 6.8% |
| Merus N V | COM | N5749R100 | $28.6M | 680,845 | 6.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $25.7M | 372,230 | 5.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $24.0M | 516,014 | 5.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $20.6M | 739,563 | 4.5% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $19.9M | 503,281 | 4.4% |
| Erasca Inc(ERAS) | COM | 29479A108 | $18.9M | 7,543,901 | 4.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $17.3M | 1,315,601 | 3.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $16.3M | 1,230,400 | 3.6% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $15.8M | 543,651 | 3.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $15.3M | 273,896 | 3.4% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $15.0M | 179,085 | 3.3% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $11.9M | 1,120,473 | 2.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $10.0M | 598,952 | 2.2% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $10.0M | 1,000,000 | 2.2% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $9.7M | 1,012,307 | 2.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $9.5M | 1,178,300 | 2.1% |
| Tela BIO Inc(TELA) | COM | 872381108 | $9.3M | 3,065,649 | 2.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $7.9M | 183,243 | 1.7% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $7.5M | 608,897 | 1.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.2M | 921,137 | 1.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.1M | 51,491 | 1.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $7.0M | 110,381 | 1.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $6.7M | 264,560 | 1.5% |
| Elutia Inc(ELUT) | CL A COM | 05479K106 | $6.7M | 1,782,271 | 1.5% |
| Biodesix Inc | COM | 09075X108 | $6.6M | 4,332,281 | 1.4% |
| Akero Therapeutics IncCall | CALL | 00973Y908 | $6.1M | 220,000 | 1.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $5.6M | 6,171,847 | 1.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $5.6M | 72,516 | 1.2% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.4M | 513,369 | 1.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $5.2M | 124,388 | 1.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.2M | 612,173 | 1.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $4.8M | 277,365 | 1.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $4.4M | 1,221,131 | 1.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $4.1M | 152,395 | 0.9% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $3.7M | 65,955 | 0.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $3.4M | 49,000 | 0.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $3.3M | 40,788 | 0.7% |
| Geron Corp(GERN) | COM | 374163103 | $3.3M | 920,022 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.0M | 734,234 | 0.7% |
| Compugen LTD(CGEN) | ORD | M25722105 | $2.5M | 1,624,377 | 0.5% |
| Cerus Corp(CERS) | COM | 157085101 | $2.4M | 1,587,228 | 0.5% |
| Syndax Pharmaceuticals IncCall | CALL | 87164F905 | $2.3M | 172,400 | 0.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $2.1M | 285,120 | 0.5% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $2.0M | 2,486,709 | 0.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.9M | 100,000 | 0.4% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $1.9M | 155,325 | 0.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.8M | 100,000 | 0.4% |
| Modular MED Inc(MODD) | COM NEW | 60785L207 | $1.7M | 1,272,015 | 0.4% |
| Kala BIO Inc(KALA) | COM NEW | 483119202 | $1.6M | 231,070 | 0.4% |